CCR5 and breast carcinoma: In breast cancer, MVC decreased the migration of CCR5+ regulatory T cells, reduced metastatic breast cancer growth in the lungs [55,67], and enhanced cell killing mediated by DNA-damaging chemotherapeutic agents [54].